company background image
1889

Sanai Health Industry Group SEHK:1889 Stock Report

Last Price

HK$0.087

Market Cap

HK$266.8m

7D

14.5%

1Y

n/a

Updated

23 Jun, 2022

Data

Company Financials
1889 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

1889 Stock Overview

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China.

Sanai Health Industry Group Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Sanai Health Industry Group
Historical stock prices
Current Share PriceHK$0.087
52 Week HighHK$0.28
52 Week LowHK$0.042
Beta1.35
1 Month Change7.41%
3 Month Change61.11%
1 Year Changen/a
3 Year Change-51.93%
5 Year Change-77.69%
Change since IPO-95.56%

Recent News & Updates

May 15
What Sanai Health Industry Group Company Limited's (HKG:1889) 35% Share Price Gain Is Not Telling You

What Sanai Health Industry Group Company Limited's (HKG:1889) 35% Share Price Gain Is Not Telling You

Those holding Sanai Health Industry Group Company Limited ( HKG:1889 ) shares would be relieved that the share price...

Shareholder Returns

1889HK PharmaceuticalsHK Market
7D14.5%5.1%-1.2%
1Yn/a-45.3%-23.8%

Return vs Industry: Insufficient data to determine how 1889 performed against the Hong Kong Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1889 performed against the Hong Kong Market.

Price Volatility

Is 1889's price volatile compared to industry and market?
1889 volatility
1889 Average Weekly Movement27.2%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement7.0%
10% most volatile stocks in HK Market13.6%
10% least volatile stocks in HK Market3.3%

Stable Share Price: 1889 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 27% a week.

Volatility Over Time: 1889's weekly volatility has increased from 19% to 27% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200681n/ahttps://www.1889hk.com

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company provides branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products.

Sanai Health Industry Group Fundamentals Summary

How do Sanai Health Industry Group's earnings and revenue compare to its market cap?
1889 fundamental statistics
Market CapCN¥227.78m
Earnings (TTM)CN¥9.03m
Revenue (TTM)CN¥67.61m

25.3x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1889 income statement (TTM)
RevenueCN¥67.61m
Cost of RevenueCN¥27.16m
Gross ProfitCN¥40.45m
Other ExpensesCN¥31.42m
EarningsCN¥9.03m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.0029
Gross Margin59.82%
Net Profit Margin13.35%
Debt/Equity Ratio0.0%

How did 1889 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 1889 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1889?

Other financial metrics that can be useful for relative valuation.

1889 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.4x
Enterprise Value/EBITDA8.2x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 1889's PE Ratio compare to its peers?

1889 PE Ratio vs Peers
The above table shows the PE ratio for 1889 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average6.9x

Price-To-Earnings vs Peers: 1889 is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the peer average (6.9x).


Price to Earnings Ratio vs Industry

How does 1889's PE Ratio compare vs other companies in the Hong Kong Pharmaceuticals Industry?

Price-To-Earnings vs Industry: 1889 is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the Hong Kong Pharmaceuticals industry average (9.4x)


Price to Earnings Ratio vs Fair Ratio

What is 1889's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1889 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio25.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1889's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 1889 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 1889's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 1889's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1889's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Sanai Health Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


5.1%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanai Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

Past Performance

How has Sanai Health Industry Group performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


66.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1889 has high quality earnings.

Growing Profit Margin: 1889's current net profit margins (13.3%) are higher than last year (5.3%).


Past Earnings Growth Analysis

Earnings Trend: 1889 has become profitable over the past 5 years, growing earnings by 66.1% per year.

Accelerating Growth: 1889's earnings growth over the past year (40.5%) is below its 5-year average (66.1% per year).

Earnings vs Industry: 1889 earnings growth over the past year (40.5%) exceeded the Pharmaceuticals industry 16.1%.


Return on Equity

High ROE: 1889's Return on Equity (7.7%) is considered low.


Discover strong past performing companies

Financial Health

How is Sanai Health Industry Group's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 1889's short term assets (CN¥188.9M) exceed its short term liabilities (CN¥90.1M).

Long Term Liabilities: 1889's short term assets (CN¥188.9M) exceed its long term liabilities (CN¥1.6M).


Debt to Equity History and Analysis

Debt Level: 1889 is debt free.

Reducing Debt: 1889 has no debt compared to 5 years ago when its debt to equity ratio was 7.1%.

Debt Coverage: 1889 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 1889 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Sanai Health Industry Group current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1889's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1889's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1889's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1889's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: 1889 is not paying a notable dividend for the Hong Kong market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 1889 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure


CEO

Sanai Health Industry Group has no CEO, or we have no data on them.


Leadership Team

Experienced Management: 1889's management team is considered experienced (2.9 years average tenure).


Board Members

Experienced Board: 1889's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sanai Health Industry Group Company Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Sanai Health Industry Group Company Limited
  • Ticker: 1889
  • Exchange: SEHK
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: HK$266.848m
  • Shares outstanding: 3.07b
  • Website: https://www.1889hk.com

Number of Employees


Location

  • Sanai Health Industry Group Company Limited
  • Nanyang Plaza
  • 7th Floor
  • Kwun Tong
  • Kowloon
  • Hong Kong

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/23 00:00
End of Day Share Price2022/06/23 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.